Susan E. Krown

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings”.

Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003236

N/A

0.645DataRank · unranked

15 citations

Di Chang, Jeannette Y. Lee, Larry Magpantay, Margaret Borok, Aggrey Bukuru +16 more

Wilms’ tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP

PLoS Pathogens(2024)10.1371/journal.ppat.1011881

N/A

0.241DataRank · unranked

4 citations

Ruby Gumenick, Caitlyn Genovese, Yun Yeong Jang, Ariene Ouedraogo, Maite Ibáñez de Garayo +24 more

WT1 Tumor Antigen is Overexpressed in Kaposi Sarcoma and is Regulated by KSHV vFLIP

medRxiv(2021)10.1101/2021.02.20.21251636

N/A

0.104DataRank · unranked

1 citations

Caitlyn Genovese, Matthew J. Bott, Julio Álvarez, Sung Soo Mun, Jennifer Totonchy +16 more

Cost-effectiveness protocol for treating adult HIV-infected patients with Kaposi sarcoma in resource-limited settings: a phase III, randomized, open-label, non-inferiority study of paclitaxel and pegylated liposomal doxorubicin

Cost Effectiveness and Resource Allocation(2025)10.1186/s12962-025-00677-x

N/A

0DataRank · unranked

0 citations

S. Kleber, Susan E. Krown, Matthew Painschab, John Chapola

Rapamycin With Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study

UNC Libraries(2020)10.17615/edcg-e734

N/A

0DataRank · unranked

7 citations

Ethel Cesarman, Erin Reid, Susan E. Krown, Debasmita Roy, Raman Venkataramanan +4 more

Serum Biomarkers in Advanced-Stage AIDS-Associated Kaposi Sarcoma in Resource Limited Settings

JAIDS Journal of Acquired Immune Deficiency Syndromes(2025)10.1097/qai.0000000000003805

N/A

0DataRank · unranked

0 citations

Carlee Moser, Younjung Choi, Margaret Borok, Thomas Campbell, Patrick MacPhail +9 more

A phase 1b/pharmacokinetic trial of PTC299, a novel post-transcriptional VEGF inhibitor, for AIDS-related Kaposi’s sarcoma: AIDS Malignancy Consortium trial 059

UNC Libraries(2020)10.17615/q862-w217

N/A

0DataRank · unranked

1 citations

Anil Tulpule, Bruce J. Dezube, Dirk P. Dittmer, Rachel Bender Ignacio, Veenadhari Chavakula +13 more

Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003484

N/A

0DataRank · unranked

0 citations

Carlee Moser, Minhee Kang, Triin Umbleja, Michael D. Hughes, Thomas Campbell +14 more